BCAX - Company ID 0002023658
Bicara Therapeutics Inc. has filed 220 public company documents between 2024 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-07-17 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-18 | 2025-06-16 | View filing |
| 144 | Insider sale notice | 1y ago2025-06-16 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-12 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 4 | Insider trade | 1y ago2025-06-10 | 2025-06-09 | View filing |
| 8-K | Major company event | 1y ago2025-06-06 | 2025-06-02 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-05-15 | - | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-13 | 2025-03-31 | View filing |
| 8-K | Major company event | 1y ago2025-05-13 | 2025-05-13 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-12 | - | View filing |
| ARS | Annual report to shareholders | 1y ago2025-04-25 | 2024-12-31 | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-25 | - | View filing |
| DEF 14A | Proxy statement | 1y ago2025-04-25 | 2025-06-09 | View filing |
| S-8 | Employee stock plan | 1y ago2025-03-28 | - | View filing |
| 10-K | Annual report | 1y ago2025-03-27 | 2024-12-31 | View filing |
| 8-K | Major company event | 1y ago2025-03-27 | 2025-03-27 | View filing |
| 4 | Insider trade | 1y ago2025-03-18 | 2025-03-14 | View filing |
| 144 | Insider sale notice | 1y ago2025-03-14 | - | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-03-03 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-12 | - | View filing |
| 8-K | Major company event | 1y ago2025-01-13 | 2025-01-13 | View filing |